Page 5 - Rosetrees Trust News Today

COVID-19 vaccine In those who have not previously been infected and have so far only received one dose of vaccine the immune response to variants of concern may be insufficient. The findings, published today in the journal Science and led by researchers at Queen Mary University of London, Imperial College London and University College London, looked at immune responses in UK healthcare workers at Barts and Royal Free hospitals following their first dose of the Pfizer/BioNTech vaccine. They f...

Queen Mary University of London In those who have not previously been infected and have so far only received one dose of vaccine the immune response to variants of concern may be insufficient. The findings, published today in the journal Science and led by researchers at Queen Mary University of London, Imperial College London and University College London, looked at immune responses in UK healthcare workers at Barts and Royal Free hospitals following their first dose of the Pfizer/BioNTech vac...

Research has used new MRI techniques to show what is happening in the brains of people with multiple sclerosis in the early stages of their condition. Scientists say these previously unseen changes could have the potential to predict how disabled a person might become in the future.<br />

Electrochemical Sensor Platform for Fast, Sensitive Detection of Biomarkers in Whole Blood Written by AZoSensorsFeb 15 2021 Many life-threatening medical conditions, such as sepsis, which is triggered by blood-borne pathogens, cannot be detected accurately and quickly enough to initiate the right course of treatment. In patients that have been infected by an unknown pathogen and progress to overt sepsis, every additional hour that an effective antibiotic cannot be administered significantly in...

 E-Mail IMAGE: Wyss Institute researchers have developed eRapid technology as an affinity-based, low-cost electrochemical diagnostic sensor platform for the multiplexed detection of clinically relevant sepsis biomarkers in whole blood. view more  Credit: Wyss Institute at Harvard University (BOSTON) -- Many life-threatening medical conditions, such as sepsis, which is triggered by blood-borne pathogens, cannot be detected accurately and quickly enough to initiate the right course of t...

 E-Mail A study by researchers at Queen Mary University in London has investigated how women who are at high risk of ovarian cancer make choices about possible preventive surgery. Women who have BRCA1 and BRCA2 genetic mutations have a 17-44% lifetime risk of ovarian cancer. Scientists now believe that most ovarian cancers begin in the fallopian tubes, and so women at high risk can choose to undergo surgery to remove both their fallopian tubes and ovaries to reduce their risk. For those who h...

 E-Mail New research suggests that a higher dietary intake of long chain omega-3 fatty acids in childhood may reduce the risk of developing subsequent asthma, but only in children carrying a common gene variant. The study, led by Queen Mary University of London, is in collaboration with the University of Bristol and University of Southampton, UK, and Karolinska Institutet, Sweden. In the UK, 1.1 million children (1 in 11) are currently receiving treatment for asthma and most adult asthma begin...

London [UK], January 28 (ANI): Researchers during a recent study have found that by higher dietary consumption of long chain omega-3 fatty acids during childhood, the risk of developing subsequent asthma reduces in children carrying a common gene variant.

Senior author, Professor Seif Shaheen from Queen Mary University of London, said: “Asthma is the most common chronic condition in childhood and we currently don’t know how to prevent it. It is possible that a poor diet may increase the risk of developing asthma, but until now most studies have taken ‘snap-shots’, measuring diet and asthma over a short period of time. Instead, we measured diet and then followed up children over many years to see who developed asthma and who didn’t. “...

 E-Mail Researchers at the Francis Crick Institute, the UCL Cancer Institute, and the Cancer Research UK Lung Cancer Centre of Excellence have identified genetic changes in tumours which could be used to predict if immunotherapy drugs would be effective in individual patients. Immunotherapies have led to huge progress treating certain types of cancer, but only a subset of patients respond, and hence a challenge for doctors and researchers is understanding why they work in some people and not ...